| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/10/2002 | WO2002079429A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 10/10/2002 | WO2002079428A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/10/2002 | WO2002079427A2 84226, a novel human cation transporter family member and uses thereof |
| 10/10/2002 | WO2002079426A2 Transgenic mice containing pai3 serine protease inhibitor gene disruptions |
| 10/10/2002 | WO2002079425A2 Transgenic mice containing clcn4 chloride ion channel gene disruptions |
| 10/10/2002 | WO2002079423A2 Delta opioid receptor disruptions, compositions and methods related thereto |
| 10/10/2002 | WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 10/10/2002 | WO2002079416A2 Transgenic animals resistant to transmissible spongiform encephalopathies |
| 10/10/2002 | WO2002079415A2 Reducing the immunogenicity of fusion proteins |
| 10/10/2002 | WO2002079408A2 Short bioactive peptides and methods for their use |
| 10/10/2002 | WO2002079407A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/10/2002 | WO2002079406A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 10/10/2002 | WO2002079404A2 Cytoskeleton-associated proteins |
| 10/10/2002 | WO2002079403A2 Method for modifying plant biomass |
| 10/10/2002 | WO2002079402A2 Method of inhibiting cancerous cell proliferation using ras mutants of gdp-bound conformation |
| 10/10/2002 | WO2002079401A2 Novel rgs9 protein binding interactions and methods of use thereof |
| 10/10/2002 | WO2002079399A2 Regulatable growth of filamentous fungi |
| 10/10/2002 | WO2002079398A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/10/2002 | WO2002079397A2 Virus derived antimicrobial peptides |
| 10/10/2002 | WO2002079394A2 Synthesis and use of glycodendrimer reagents |
| 10/10/2002 | WO2002079390A2 $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof |
| 10/10/2002 | WO2002079389A2 Nucleic acid-associated proteins |
| 10/10/2002 | WO2002079386A2 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/10/2002 | WO2002079385A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/10/2002 | WO2002079384A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/10/2002 | WO2002079383A2 Fizz1 for metabolism regulation |
| 10/10/2002 | WO2002079382A2 B-ephrin regulation of g-protein coupled chemoattraction; compositions and methods of use |
| 10/10/2002 | WO2002079380A2 Disruptions in gaba receptor rh02 subunit, methods adn uses thereof |
| 10/10/2002 | WO2002079299A1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 10/10/2002 | WO2002079253A1 Wti modified peptide |
| 10/10/2002 | WO2002079252A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof |
| 10/10/2002 | WO2002079251A2 Method for making human insulin precursors |
| 10/10/2002 | WO2002079250A1 Insulin precursors and a process for their preparation |
| 10/10/2002 | WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene |
| 10/10/2002 | WO2002079248A2 Mammalian alpha-helical protein-53 |
| 10/10/2002 | WO2002079247A2 Intimins in the prevention or treatment of infections:ii |
| 10/10/2002 | WO2002079246A2 Human arginine-rich protein-related compositions |
| 10/10/2002 | WO2002079245A2 Method for improving plant tolerance to environmental stress |
| 10/10/2002 | WO2002079244A2 Chlamydial protease-like activity factor responsible for degradation of host transcription factor |
| 10/10/2002 | WO2002079243A2 Gonococcal proteins and nucleic acids |
| 10/10/2002 | WO2002079242A2 Adp-ribosylating bacterial toxins |
| 10/10/2002 | WO2002079241A2 Secreted streptococcus pneumoniae proteins |
| 10/10/2002 | WO2002079240A2 Intimins for the prevention or treatment of infections: i |
| 10/10/2002 | WO2002079239A2 Chimeric filovirus glycoprotein |
| 10/10/2002 | WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 10/10/2002 | WO2002079237A2 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof |
| 10/10/2002 | WO2002079236A1 Alpha conotoxin peptides with analgesic properties |
| 10/10/2002 | WO2002079232A2 Reducing the immunogenicity of fusion proteins |
| 10/10/2002 | WO2002079231A2 Nucleic acids encoding isav polypeptides |
| 10/10/2002 | WO2002079230A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 10/10/2002 | WO2002079229A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/10/2002 | WO2002079227A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/10/2002 | WO2002079225A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/10/2002 | WO2002079222A2 Fusion proteins for specific treatment of cancer and auto-immune diseases |
| 10/10/2002 | WO2002079217A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
| 10/10/2002 | WO2002078735A2 Leishmania vaccines |
| 10/10/2002 | WO2002078734A1 Production of peptides in plants as n-terminal viral coat protein fusions |
| 10/10/2002 | WO2002078732A1 A noval vaccine formulation consisting of dna vaccine inactivated virus |
| 10/10/2002 | WO2002078731A1 Module of pd-1 interactions with its ligands |
| 10/10/2002 | WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain |
| 10/10/2002 | WO2002078729A1 Compositions and methods for diagnosing or treating psoriasis |
| 10/10/2002 | WO2002078715A1 Method for induction of an antigen specific anti-inflammatory response |
| 10/10/2002 | WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 10/10/2002 | WO2002078642A2 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer |
| 10/10/2002 | WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 10/10/2002 | WO2002078636A2 Detection and treatment of colorectal cancer |
| 10/10/2002 | WO2002078635A2 Estrogen receptor modulators |
| 10/10/2002 | WO2002078631A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 10/10/2002 | WO2002078630A2 Tub 3'-variant |
| 10/10/2002 | WO2002078624A2 Aerosol administration of interleukin-2 liposomes |
| 10/10/2002 | WO2002078621A2 Replication-competent recombinant virus and methods of use thereof |
| 10/10/2002 | WO2002078614A2 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof |
| 10/10/2002 | WO2002078613A2 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 10/10/2002 | WO2002078609A2 Immunoglobulin construct containing tumor specific p53bp2 sequences for eliciting an anti-tumor response |
| 10/10/2002 | WO2002078607A2 Mucin peptide with immunoenhancing properties |
| 10/10/2002 | WO2002078606A2 Thrombospondin-2 and uses thereof |
| 10/10/2002 | WO2002078603A2 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine |
| 10/10/2002 | WO2002078598A2 Peptides and antibodies to muc 1 proteins |
| 10/10/2002 | WO2002078597A2 Oral absorbed drugs |
| 10/10/2002 | WO2002078526A2 Cancer-testis antigens |
| 10/10/2002 | WO2002078524A2 Translational profiling |
| 10/10/2002 | WO2002078516A2 Compositions and methods for the therapy and diagnosis of cancer |
| 10/10/2002 | WO2002078451A1 Pesticidal compositions from prunus |
| 10/10/2002 | WO2002078438A2 Tissue-preferred promoter from maize |
| 10/10/2002 | WO2002078437A2 Novel pesticidal toxins |
| 10/10/2002 | WO2002078435A1 Transgenic mice containing gnb1 gene disruptions |
| 10/10/2002 | WO2002078427A2 Specification of meiocyte and tapetal cell layers in plants |
| 10/10/2002 | WO2002078426A2 Final segregation of male meiotic products in plants |
| 10/10/2002 | WO2002078420A2 Molecules for disease detection and treatment |
| 10/10/2002 | WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 10/10/2002 | WO2002063018A3 Method for the production of plant seed with modified fibre content and modified seed coat |
| 10/10/2002 | WO2002059149A3 Pro-apoptotic proteins and dna molecules encoding them |
| 10/10/2002 | WO2002057305A9 A gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages |
| 10/10/2002 | WO2002053734A3 Methods and compositions for inhibiting neoplastic cell growth |
| 10/10/2002 | WO2002032930A3 Haplotypes of the scya21 gene |
| 10/10/2002 | WO2002032642A3 Electroprocessing polymers to form footwear and clothing |
| 10/10/2002 | WO2002029069A3 A nitrate-responsive plant root specific transcriptional factor |
| 10/10/2002 | WO2002029045A3 Method for the production of vitamin k-dependent proteins |
| 10/10/2002 | WO2002029025A3 Factor vii glycoforms |
| 10/10/2002 | WO2002026820A3 Immunomodulatory protein derived from the yaba monkey tumor virus |